Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive Factors-Reference-Cited by-同舟云学术

Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive Factors

Published:2023 Issue: Volume:41 Page:
ISSN:2287-4208
Container-title:The World Journal of Men's Health
language:en
Short-container-title:World J Mens Health

Author:

Hong Jian-Hua¹^ORCID,Kuo Ming-Chieh¹²^ORCID,Cheng Yung-Ting³^ORCID,Lu Yu-Chuan¹⁴^ORCID,Huang Chao-Yuan¹^ORCID,Liu Shih-Ping¹^ORCID,Chow Po-Ming¹^ORCID,Huang Kuo-How¹^ORCID,Chueh Shih-Chieh Jeff¹^ORCID,Chen Chung-Hsin¹^ORCID,Pu Yeong-Shiau¹^ORCID

Affiliation:

1. Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.

2. Department of Urology, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.

3. Department of Urology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.

4. Department of Surgical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.

Funder

Ministry of Science and Technology, Taiwan

Publisher

XMLink

Subject

Pharmacology (medical),Urology,Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health Policy,Aging,Reproductive Medicine

Link

https://wjmh.org/pdf/10.5534/wjmh.230107

Reference30 articles.

1. Health Promotion Administration, Ministry of Health and Welfare. The incidence of prostate cancer from 1979 to 2018 in Taiwan [Internet]. HPA. c2020. cited 2021 Aug 27. Available from: https://www.hpa.gov.tw/File/Attach/13498/File_21195.pdf

2. . Network NCC. Prostate cancer (Version 2.2022) [Internet]. National Comprehensive Cancer Network. c2022. cited 2022 Apr 1. Available from: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

3. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort

4. Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial

5. Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer